These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3774652)

  • 21. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero.
    Eisenstein Z; Weiss M; Katz Y; Bank H
    Eur J Pediatr; 1992 Aug; 151(8):558-9. PubMed ID: 1505570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy of Basedow's disease].
    Ishii J
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):868-72. PubMed ID: 1700042
    [No Abstract]   [Full Text] [Related]  

  • 23. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
    Iwayama H; Hosono H; Yamamoto H; Oshiro M; Ueda N
    Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):680-4. PubMed ID: 17803201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithyroid drugs.
    Cooper DS
    N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aplasia cutis congenita and antithyroid drugs during pregnancy: Case series and literature review].
    Sachs C; Tebacher-Alt M; Mark M; Cribier B; Lipsker D
    Ann Dermatol Venereol; 2016; 143(6-7):423-35. PubMed ID: 27033749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Choanal atresia associated with the use of tapazol during pregnancy].
    Fagundes TA; Reis JS; Rosário PW; Carvalho PA; Purisch S
    Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1551-2. PubMed ID: 18209901
    [No Abstract]   [Full Text] [Related]  

  • 27. Aplasia cutis congenita after methimazole exposure in utero.
    Karg E; Bereg E; Gaspar L; Katona M; Turi S
    Pediatr Dermatol; 2004; 21(4):491-4. PubMed ID: 15283799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of maternal hyperthyroidism and its treatment on fetus-maternal ingestion of antithyroid drug, maternal hyperthyroidism, and congenital malformation (author's transl)].
    Momotani N
    Horumon To Rinsho; 1981 Jul; 29(7):783-7. PubMed ID: 6895490
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbimazole embryopathy in a Chinese population: case series and literature review.
    Ting YH; Zhou Y; Lao TT
    Birth Defects Res A Clin Mol Teratol; 2013 Apr; 97(4):225-9. PubMed ID: 23457082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism.
    Momotani N; Noh JY; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3633-6. PubMed ID: 9360518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antepartal nursing management of Grave's disease.
    Karacic B
    J Obstet Gynecol Neonatal Nurs; 1986; 15(3):214-8. PubMed ID: 3635591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
    Andersen SL; Olsen J; Wu CS; Laurberg P
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aplasia cutis congenita: a clinical review and proposal for classification.
    Frieden IJ
    J Am Acad Dermatol; 1986 Apr; 14(4):646-60. PubMed ID: 3514708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe malformations in infant born to hyperthyroid woman on methimazole.
    Johnsson E; Larsson G; Ljunggren M
    Lancet; 1997 Nov; 350(9090):1520. PubMed ID: 9388405
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new possible phenotype of carbimazole embryopathy: A case report].
    Mellerio H; Gay CL; Forest MG; Orgiazzi J; Nicolino M
    Arch Pediatr; 2010 May; 17(5):511-6. PubMed ID: 20395117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.